Category: Life Sciences
Global Life Sciences
-
Medicated Skin Care Products
... 2030, growing at a CAGR of 3.1% over the analysis period 2024-2030. Medicated Cleansers, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$2.9 Billion by the ... Read More
-
Algae Omega 3 Ingredients
... 2030, growing at a CAGR of 9.8% over the analysis period 2024-2030. EPA / DHA, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach US$1.0 Billion by ... Read More
-
Pneumatic Compression Therapy
... at a CAGR of 4.7% over the analysis period 2024-2030. Pneumatic Compression Sleeves, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$483.0 Million by the end ... Read More
-
Scintillators
... 4.9% over the analysis period 2024-2030. Inorganic Scintillators, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$492.3 Million by the end of the analysis period. Growth ... Read More
-
Surgical Drapes and Gowns
... 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Surgical Drapes, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$3.1 Billion by the ... Read More
-
eCommerce and Other Non-Store Retailers
... Trillion by 2030, growing at a CAGR of 13.1% over the analysis period 2024-2030. eCommerce Retailers, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$7.8 Trillion ... Read More
-
Tuberculosis Testing
... CAGR of 4.9% over the analysis period 2024-2030. Culture-Based Tests, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$714.5 Million by the end of the analysis ... Read More
-
Medical Imaging Equipment Services
... 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Equipment Repair & Maintenance Services, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$17.9 ... Read More
-
Intravenous (IV) Iron Drugs
... 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$2.3 Billion by the ... Read More
-
Corporate Wellness
... CAGR of 6.5% over the analysis period 2024-2030. Health Risk Assessment, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$27.9 Billion by the end of the ... Read More
-
Cycling Power Meters
... at a CAGR of 4.4% over the analysis period 2024-2030. Crank Arm-Based Power Meters, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$197.5 Million by the ... Read More
-
Digital Health
... CAGR of 17.9% over the analysis period 2024-2030. mHealth, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$467.5 Billion by the end of the analysis period. ... Read More
-
Laboratory Information Systems (LIS)
... 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. Standalone LIS, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.6 Billion by the ... Read More
-
Microplate Systems
... CAGR of 4.6% over the analysis period 2024-2030. Microplate Readers, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$851.2 Million by the end of the analysis ... Read More
-
Pharmaceutical Packaging
... CAGR of 8.2% over the analysis period 2024-2030. Plastics & Polymers Material, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$114.0 Billion by the end of ... Read More
-
Skin Rejuvenation Devices
... at a CAGR of 8.9% over the analysis period 2024-2030. Intense Pulsed Light (IPL) Devices, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$1.3 Billion by ... Read More
-
Single Photon Emission Computed Tomography (SPECT)
... reach US$3.3 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Standalone SPECT, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach ... Read More
-
Vendor Neutral Archive (VNA) and PACS
... reach US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. PACS, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.4 ... Read More
-
Contraceptives
... 6.3% over the analysis period 2024-2030. Contraceptive Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$26.0 Billion by the end of the analysis period. Growth ... Read More
-
Blood Glucose Monitoring Systems
... 2030, growing at a CAGR of 10.0% over the analysis period 2024-2030. Self-Monitoring Systems, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$21.4 Billion by the ... Read More
-
Cancer Stem Cells
... at a CAGR of 8.5% over the analysis period 2024-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the ... Read More
-
Intracranial Aneurysm
... CAGR of 8.7% over the analysis period 2024-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
IR Spectroscopy
... CAGR of 5.1% over the analysis period 2024-2030. Benchtop IR Spectroscopy, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$647.6 Million by the end of the ... Read More
-
Lactoferrin
... 7.0% over the analysis period 2024-2030. Iron Absorption Function, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$161.1 Million by the end of the analysis period. ... Read More
-
Live Cell Encapsulation
... at a CAGR of 3.8% over the analysis period 2024-2030. Alginate Polymer, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$117.8 Million by the end of ... Read More
Research Assistance
